A Phase III Randomized Feasibility Study Comparing Stereotactic Body Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) For Patients With Spinal Metastases
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Clinical Trial Registration
Related Post
31 March, 2026
TROG Secondary Data Analysis Grant awarded to project to better understand prostate cancer therapy outcomes
LATEST NEWS: 31 March 2026 TROG’s inaugural Secondary Data
26 March, 2026
TROG welcomes new Board members and President-Elect
LATEST NEWS: 26 March 2026 We are delighted to